| Literature DB >> 31384325 |
Emilia Rusu1, Georgiana Enache1,2, Raluca Cursaru1, Alexandra Alexescu1, Raluca Radu1, Oana Onila1, Teodora Cavallioti1, Florin Rusu3, Mihaela Posea4, Mariana Jinga5, Gabriela Radulian1.
Abstract
Recent years have brought additional data on the benefits of prebiotics and probiotics treatment in patients with atopic dermatitis. This review includes all the articles published in PubMed, Scopus, Embase and Cochrane databases until 05.06.2018. The terms used for the search were 'prebiotic', 'probiotic', 'atopic dermatitis', 'Severity Scoring of Atopic Dermatitis', and 'SCORAD'. There was an increase of the intestinal permeability reported in patients with atopic dermatitis and a reduction of the cutaneous microbiome diversity. Probiotics modulate the general microbiome and immune status by improving the intestinal barrier; these effects can be responsible for reducing allergic phenomenon and atopic dermatitis severity. We have structured the results by age groups as infants, 1-18 years, adults, and also pregnancy and lactation. Literature does not offer yet answers on the issues such as the optimal dosing, duration needed to see beneficial effects, the optimal time to start the treatment; the personalized use of probiotics according to colonic dysbiosis may be associated with better results. However, most randomized controlled trials and meta-analyzes support the administration of probiotics for at least 8 weeks in order to obtain beneficial effects in improving severity scoring of atopic dermatitis.Entities:
Keywords: SCORAD; atopic dermatitis; prebiotic; probiotic
Year: 2019 PMID: 31384325 PMCID: PMC6639913 DOI: 10.3892/etm.2019.7678
Source DB: PubMed Journal: Exp Ther Med ISSN: 1792-0981 Impact factor: 2.447